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Abstract
The adoption of agent technologies and multi-agent systems constitutes an emerging area in bioinformatics. In this
article, we report on the activity of theWorking Group on Agents in Bioinformatics (BIOAGENTS) founded during
the first AgentLink III Technical Forum meeting on the 2nd of July, 2004, in Rome. The meeting provided an
opportunity for seeding collaborations between the agent and bioinformatics communities to develop a different
(agent-based) approach of computational frameworks both for data analysis and management in bioinformatics and
for systems modelling and simulation in computational and systems biology. The collaborations gave rise to applica-
tions and integrated tools that we summarize and discuss in context of the state of the art in this area.
We investigate on future challenges and argue that the field should still be explored frommany perspectives ranging
from bio-conceptual languages for agent-based simulation, to the definition of bio-ontology-based declarative
languages to be used by information agents, and to the adoption of agents for computational grids.
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INTRODUCTION
The avalanche of data that has been generated,
particularly in biological sequences and more
recently also in transcriptional and structural data,
interactions and genetics, has led to the early
adoption of tools for unsupervized automated
analysis of biological data during the mid-1990s
[1, 2]. Computational analysis of such data has
become increasingly more important, and many
more tools and models for the interpretation of
biological data have been developed in recent years.
However, not all of these are publicly available or
permit bulk submissions via the web. Moreover,
some tools require training, particularly for indi-
vidual organisms, and tools may be mutually
interdependent.
The reason for establishing a Working Group on
Agents in Bioinformatics (BIOAGENTS) was to
achieve improvements in the field of bioinformatics
by designing and implementing new flexible infor-
mation and communication technologies tools
able to support biological science data analysis and
to distribute, at least partially, the computation
burden, while reducing the need for the transfer
of huge amounts of data. From this perspective,
it is believed that software agents can play a major
role. The scope of the Working Group was
to promote a collaboration between the agent
and bioinformatics communities, with the aim
of creating synergies for modelling complex bio-
logical systems. As suggested by the AgentLink II
Roadmap [3], one of the most promising emerging
application domains for agent technologies is the
biological sciences, both in relation to multi-agent
systems for simulating and modelling biological
systems, and for supporting the automation of
information-gathering and information-inference
processes.
AgentLink III (http://www.agentlink.org) was
a coordination action for agent-based computing,
funded by the European Commission’s 6th
Framework Programme, which provides support
for researchers and developers with a common
interest in agent-based computing. One of the
most important and visible activities of AgentLink
III has been concerned with organizing a periodic
Technical Forum (AL3-TF), in which Technical
Forum Groups (TFGs) meet to discuss issues of key
interest to the agent community. In 2004, AgentLink
organized the first Technical Forum, held from
the 30th of June to the 2nd of July, in Rome, Italy,
at which the first BIOAGENTS Technical Forum
Group founded the Working Group [4].
Here, we report on the state of the art in using
agents in bioinformatics, presenting the activities
and results of the Working Group and future
perspectives. In particular, subsequent sections first
introduces ‘Agents and multi-agent systems’, then
motivates the use of ‘Agents in bioinformatics’ by
discussing recent experiences within BIOAGENTS
& points out ‘Future challenges’ of agents in
bioinformatics & finally concludes the article.
AGENTSANDMULTI-AGENT
SYSTEMS
Agents can be considered as a distinct kind of
software abstraction, in the same way that methods,
functions and objects are software abstractions.
More specifically, an agent is a high-level software
abstraction that provides a convenient and powerful
way to describe a complex software entity in terms
of its behaviour within a contextual computational
environment. It differs from an object in the
capability to control its own state. The weak notion
of agents is of flexible problem-solving computa-
tional entities that are reactive (respond to the
environment), proactive (maintain overarching
goals), autonomous (not externally controlled) and
interact with other such entities. By contrast, the
strong notion views agents as composed of particular
mental or cognitive abilities, suggesting agent
architectures based on the belief–desire–intention
model. The weak form has relatively low-level
agents that do little computation processing, and the
outcomes emerge from the results of the interactions
of large numbers of agents. The coarser grained
agents yield higher-level of communication and
stronger individual problem-solving capabilities.
Building on this premise, multi-agent systems, in
which multiple agents interact in some overarching
system architecture, have been argued to be a
particularly suitable level and means of abstraction
for solving complex problems. This is achieved
through the modelling and engineering of complex
systems [5], which are characterized by organization
structures and coordination processes that are
increasingly better articulated and more dynamic
than alternative forms [6].
In this view, an agent is a computer system
capable of flexible, autonomous problem-solving
actions; it is capable of operating as a stand-alone
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process, and performing actions without user inter-
vention by maintaining a description of its own
processing state and the state of environment in
which it is situated. The environments in which
agents operate are typically dynamic, open, unpre-
dictable and populated by other agents. An agent
must therefore also be able to communicate with
other agents and the execution environment
itself [7, 8].
A communication act between two agents is
facilitated if a suitable ontology exists, shared by
both agents. The communication itself is distinct,
however. For example, agent communication lan-
guages such as KQML [9] or FIPA ACL (http://
www.fipa.org) provide the performatives (or types
of message) that may be required here, but both
allow for the specification of a particular ontology
to ensure that the content of the message is
understood by both the parties. The use of
ontologies guarantees agreement on the semantics
of the exchanged data. Moreover, whenever an
agent acquires additional information, it can integrate
it with its personal knowledge base. Each agent is
responsible for the consistency and the correctness
of this operation.
Agents provide designers and developers with
a way of structuring an application around auton-
omous, communicative elements, and lead to the
construction of software tools and infrastructure
to support the design metaphor. In this sense, they
offer a new and often more appropriate route to the
development of complex systems. In order to
support this view of systems development, particular
tools and techniques need to be used: from agent
computing platforms to support the design and
engineering of agents and multi-agent systems, to
more general infrastructures supporting the integra-
tion of current technologies, such as web services.
However, agent technologies are distinct in spanning
a range of specific techniques and algorithms for
dealing more specifically with interactions with
others in these dynamic and open environments.
Such techniques include those for learning from,
and about, other agents in the environment and user
preferences, finding ways to negotiate and cooperate
with agents, and developing appropriate means of
forming and managing coalitions. With the increas-
ing prevalence of agent-based computing in recent
years, research on agent-oriented software engineer-
ing (AOSE) [6, 10] has also led to the proposal of
several models, methodologies and tools to guide the
analysis and design of complex systems in this
context.
AGENTS IN BIOINFORMATICS
Agent technology deals with entities typically
equipped with information management and
coordination capabilities. The notion of agents in
bioinformatics thus suggests the support of integra-
tion of information by designing domain-aware
information agents for knowledge management and
problem-solving within a biological domain. The
use of agents in computational and systems biology
suggest the design of agent-based systems, tools and
languages for modelling the biological processes
themselves.
At the dawn of the ‘omics’ age, bioinformatics
was defined [11] as a computational discipline aiming
at the management and analysis of biological data.
Nowadays, we should also include in this definition
the capability to address information and knowledge
overflow as well—integration has become the
password. Computational biology focuses more on
the algorithmic aspects, often taking into account
biomolecular concepts or even mimicking them
[12]. Systems biology attempts to understand the
emerging behaviour of biological systems as a whole
[13]. The three disciplines are so strongly correlated
and integrated that in the rest of the article we
dwell on them.
Agents proved to be useful for the applications
that imply: repetitive and time-consuming activities;
knowledge management, such as integration of
different knowledge sources and modelling of
complex, dynamic systems. All of these are typical
tasks in the aforementioned disciplines. In particular,
the kinds of resources available in the bioinformatics
domain, with numerous databases and analysis
tools independently administered in geographically
distinct locations, lend themselves almost ideally to
the adoption of a multi-agent approach. Here, the
environment is open, distributed and dynamic, with
resources entering and leaving the system over time.
There are likely to be large numbers of interactions
between entities for various purposes, and the need
for automation is substantial and pressing. Some early
work in this direction, using agents for genome
analysis, is demonstrated by the GeneWeaver project
in the UK [14], and work using DECAF in the US
[15, 16]. Earlier work [1, 17] does not mention
agents explicitly but shares many similar concepts.
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Recently, Keele and Wray [18] reviewed the issues
concerning applications of software agent technology
to genomics. In Italy, results in the application of
agents to data and tools integration, have been
provided by the BioAgent project [19–22]. For
biological systems simulation, early work demon-
strates the use of agent technology to model
intracellular signalling pathways [23], and in visual
tools for cell modelling [24]. More substantial
work is now underway on the use of distributed
components as part of the UK’s myGrid [25]
e-Science project (http://www.mygrid.org.uk),
developing a Bioinformatics Grid testbed, which
may also merit the application of the agent paradigm
[26]. Another project, with a special applications for
biology, is the Italian Grid.it (http://www.grid.it);
this project aims to provide platforms for
high-performance computational grids oriented at
scalable virtual organizations. Promising experi-
mental studies on the integration of Grid and
agent technology are also being carried out in the
framework of a new project, LITBIO (Interactive
Laboratory of Bioinformatics Technologies; http://
www.litbio.org).
Recent experiences
In this section, we report on some recent experiences
in using agents in bioinformatics, and discuss the
results obtained in employing them both as assistants
for bioinformaticians and as problem solvers for
biologists. More details of each application can be
found in the corresponding references.
Bioinformatics process automation
In order to illustrate the role of agents in bioinfor-
matics process automation, we consider the experi-
ence of GeneWeaver [14], which is a multi-agent
system aimed at addressing concerns with the
management of data and analysis methods for
bioinformatics. It comprises a community of agents
that interact with each other, each having a particular
role, in an overall effort to automate processes
involved in bioinformatics. The system was targeted
at genome annotation, but should not really be
viewed as satisfying a single need, with each agent
being able to deliver its own expertise at solving
particular problems. If we consider the kinds of
problems that are common in such applications,
including filtering and prioritizing information
resulting from matched proteins, integrating several
distinct analysis programs possibly in sophisticated
ways, managing multiple remote sources of data
in different formats, and so on, no solution for
automation suggests itself quite as much as a multi-
agent approach. In fact, this kind of problem is
not really novel—it fits what might be considered
a standard model of a multi-agent system in a
traditional information systems domain with the
addition of some extra complications and a different
set of data.
Agents in the system can be concerned with
management of the primary databases, performing
sequence analyses using existing tools, or with storing
and presenting resulting information. The important
point to note is that the system does not offer
new methods for performing these tasks, but
organizes existing ones for the most effective and
flexible operation.
There are five types of agents present in the
GeneWeaver community.
 Broker agents are facilitators rather than points
of functionality, needed to register information
about other agents in the community.
 Primary database agents are needed to manage
remote primary sequence databases and keep the
data contained in them up-to-date, and in a
format that allows other agents to query that data.
 Non-redundant database agents construct and
maintain non-redundant databases from the data
managed by other primary database agents in the
community.
 Calculation agents encapsulate some pre-existing
methods or tools for analysis of sequence data,
and attempt to determine the structure or function
of a sequence. Whenever possible, they are also
responsible for constructing and managing any
underlying data that they rely on.
 Genome agents are responsible for managing the
genomic information for a particular organism.
Agents for the analysis of polygenic diseases
It is often not clear if a gene is expressed or
differentially expressed. It is even more difficult to
determine if an observed change is relevant for
a disease. Humans are not good in ranking these
findings, particularly not for complex diseases, with
many contributing factors. A laboratory investigating
a particular disease is likely to have both RNA and
protein expression data from many different sources.
The data are likely to include information from
cell cultures, experiments prior, and post, to the
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inhibition of a particular set of genes, nucleotide
polymorphisms and the same for animal models of
the disease from multiple strains. Also of particular
interest is the genotyping of animals, from which
identifications of chromosomal loci that contribute
to the disease may be inferred.
The use of agents for the analysis of polygenic
diseases and preliminary results on combining RNA
and protein expression levels, genotyping and
intergenomics by adopting BioAgent, a program-
ming environment based on mobile middleware
[20], are encouraging. Agent technology supports
uniform access to local and public data (through a
facilitator, i.e. a wrapper of web services or local
tools, as implemented by EDITtoTrEMBL and other
efforts [1, 17, 27]). Agent technology helps in
understanding links between data sources and their
association with diseases, providing reasoning over
these data to yield a model of the disease in terms of
the minimal number of genes/pathways that explain
the maximal number of observations of the disease.
Agents gather annotation of protein or genomic
sequences and establish a consensus, as implemented
for information from protein domain databases and
trans-membrane protein sequence annotation [28].
In this context, agents are viewed not only as a
technical implementation of distributed computing,
but also as a manager of different views on the
collected data, from which a complete model needs
to be inferred.
Many other sources of information are available as
web services that agents may provide. These include
selection of nucleotide polymorphisms [29], conver-
sion between genetic and physical distances [30]
and inter-genomic consensus regions of disease
association [31] which, today, are queried only
manually and independently.
Agents could also be used to select preferred
investigations of particular regions of 2D-gels,
e.g. zooming in on gels, mass spectrometry (MS)-
identification of spots, and searching for predicted
variants. They might also suggest investigation of
genes that are not on a microarray chip by
intelligently supporting the huge computational
effort required, which could benefit from load
sharing in the context of grid computing.
myGrid practical experience in tasks automation
One of the key problems facing bioinformaticians is
the task of finding the services and the data that they
need to perform in silico experiments. This task is
complex for several reasons. First, the tools are often
widely distributed, maintained by many different
decentralized groups. Secondly, there are many
different tools, performing many different kinds
of operation, on many different kinds of data. And,
finally, this is further complicated by the lack of formal
standards for representing the data of bioinformatics.
It is against this backdrop that the myGrid project
operates. The project has built a service-oriented
system that enables the publication and composition
of tools as services [32], recognizing that service
autonomy and heterogeneity are the key challenges
in bioinformatics, rather than the requirement for
high performance, which was the original focus of
computational Grid technologies. While this simpli-
fies some of the difficulties described earlier—it is
no longer necessary to ‘screen scrape’ web pages—it
does not address the difficulties of complexity.
This environment is one that seems ripe for
the application of agent technology; coping with
distribution, decentralization and complexity are
some of the biggest perceived advantages of this
technology. However, to enable the use of agents,
large amounts of knowledge are required in a form
that can be processed by the agent. Towards this
aim, myGrid has made heavy use of semantic web
technologies, focusing on providing descriptions
of the services that support the task of discovering
and composing services, in a manner that facilitates
and supports the work of the bioinformatician [33].
Currently, this work is very much ‘user-oriented’:
the knowledge is provided by the user and the
main service discovery agent is the user. However,
it is now investigating techniques for making
more automated use of this knowledge, in particular
shim services—those services that align closely
related data—enabling the bioinformatician to
combine services without having to worry about
complexity and reducing the difficulties resulting
from the use of the flat files and informal
representations [34].
In addition to the task of discovery of tools and
data sets, myGrid has attempted to address some of
the difficulties in organizing and storing knowledge
about the derivation or provenance of data generated
by its service-oriented architecture [35]. This is
traditionally a difficulty in bioinformatics, where it is
often hard to determine what information was used
to draw a given conclusion, resulting in databases
that are error prone and possibly circular. Again,
the focus has been on user interaction with this data,
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but using formats that should be computationally
accessible to agents.
The experiences of myGrid highlight some of
the barriers to the adoption of agent technology.
There is a continual tension between the desire for
agents to use rich and expressive knowledge, with
the complexity of actually obtaining this informa-
tion. myGrid has generally used simpler technologies
and much less expressive representations. This
reduces the effort required to obtain the knowledge,
but, probably, also reduces the application of it.
Despite these difficulties, myGrid is an evidence of
the importance of marrying computer science
research with bioinformatics. Semantic web and
agent technologies offer much for reducing the
complexity of the tasks of bioinformatics, while
bioinformatics offers a rich domain with real world
problems for the computer scientist. As bioinfor-
matics continues to increase the formalization in
the data and the desire for automation, both the
resources needed and the requirements for multi-
agent systems are becoming clearer.
An agent-based semantic web for bioinformatics
The power of ontologies and the idea of the
semantic web is evident from novel applications
such as GoPubMed (www.gopubmed.org), an
ontology-based literature search engine [36]. In a
first step, GoPubMed automatically identifies
GeneOntology [37] terms in PubMed literature
abstracts and tags the abstracts accordingly. In this
respect, GoPubMed changes web contents to
semantic web contents. In a second step, it allows
users to explore PubMed search results with the
GeneOntology. The categories of the ontology help
users quickly to survey and group abstracts according
to relevant categories rather than working through
a list of papers. And, it allows task automation by
providing agents with a large amount of knowledge
in a form that can readily be processed.
www.Prova.ws: rule-based java scripting
Semantic web applications such as GoPubMed
integrate ontologies and other data sources such as
PubMed. In general, there is therefore a need
for bioinformatics system integration specifically
supporting reasoning over structured vocabularies.
Prova [38], a language for rule-based Java-scripting,
aims to address this need. Prova has been used
e.g. to implement the first GoPubMed prototype.
The use of rules allows one to specify declaratively
the integration needs at a high-level without any
implementation details. The transparent integration
of Java caters for easy access and integration of
database access, web services and many other Java
services. This way, Prova combines the advantages
of rule-based programming and object-oriented
programming in Java. The Prova language is
positioned as a platform for knowledge-intensive
ontology-rich (most likely, agent-based) applications
in biomedical research. It aims to satisfy the
following design goals: combine the benefits of
declarative and object-oriented programming; merge
the syntaxes of Prolog as a rule-based language and
Java as an object-oriented language; expose logic as
rules; access data sources via wrappers written in Java
or command-line shells like Perl; make all Java
Application Programming Interfaces (APIs) from avail-
able packages directly accessible from rules; run within
the Java runtime environment; be compatible with
web-based and agent-based software architectures
and provide functionality necessary for rapid applica-
tion prototyping and low-cost maintenance.
Differently from other reasoners (e.g. RACER
[39]), Prova supports the use of agents for reasoning
over such ontologies and integrating them with
databases and web services. Karasavvas and colleagues
[40] also argue for the importance of an agent
communication language (and a standard derived
from it) in the perspective of bioinformatics integra-
tion systems. Furthermore, they evaluate criticality
issues concerning the decisions to be taken in
bioinformatics integration systems [41].
Protein secondary structure prediction
The problem of predicting protein 3D-structure
is very complex, as the underlying process involves
biological, chemical and physical interactions. A
simplified task is to predict the secondary structure,
i.e. the local conformation of the peptide chain
projected into a one-dimensional sequence. Despite
this simplification, information about secondary
structure often provides useful information for
predicting protein functional sites, which justifies
the interest of researchers in this particular and
exciting field. Artificial neural networks (ANNs)
have been widely applied to this task [42, 43] and
represent the core of many successful secondary
structure prediction methods, thanks to their ability
to find patterns without the need for predetermined
models or known mechanisms. In fact, all modern
methods actually resort to ensembles of ANNs,
usually organized into different functional levels.
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In relation to agents, one architecture in which the
existence of separate ‘experts’ is clearly articulated
has been proposed in [44]. To predict the secondary
structure of a protein, the corresponding system,
called MASSP (MultiAgent Secondary Structure
Predictor), resorts to a population of homogeneous
experts—each expert being implemented by a
software agent that embodies a genetic and a
neural component (i.e. guard and embedded pre-
dictor, respectively). Guards and predictors perform
different tasks and are supplied with different
information. In particular, a guard is aimed at
(soft-)partitioning the input space, insomuch as
assuring both the diversity and the specialization of
the corresponding embedded predictor, which in
turn is devoted to perform the actual prediction.
Guards deal with inputs that encode information
strictly related with relevant domain knowledge,
whereas embedded predictors process other relevant
inputs, each consisting of a limited window of
residues. In the current release of the system, agent
technology in its full potential is used, Jade [45]
being adopted as underlying programming frame-
work. Although, experimental results are already
promising—an accuracy of about 76%, measured in
terms of Q3, has been reached—the adoption of the
agent technology is mainly due to the requirements
imposed on the next release of the system—which is
expected (i) to implement complex interactions, (ii)
to implement heterogeneous experts and (iii) to
integrate predictions performed by other predictors
disseminated over the Internet. In fact, software
agents are perfectly suited to fulfil the requirements
above, as they offer a new paradigm for very large-
scale distributed heterogeneous applications, focused
on the interactions of autonomous, cooperating
processes (for further details see, for instance,
Bradshaw [46]). Regarding the first of the above
issues, let us stress that the environment in which
MASSP experts operate basically stems from that
dictated by the basic rules of evolutionary computa-
tion, in which the main schema of interaction is
based on competition. Thus, more complex and
flexible forms of interaction may be difficult to
implement, in particular to enable experts to apply
different policies in accordance with the current state
of the computation and with the current operational
context. Fortunately, interaction is a key focus
of agent technology (see, for instance [47]), which
involves communication languages and inter-
action protocols. As for the second issue
(i.e. heterogeneity), it is clear that the ability to
deal with experts able to process different kinds of
data, either locally available, or downloaded from
the Internet, creates a scenario in which automated
experts can mimic the workflow activity performed
by human experts, which are able to cooperate in
predicting secondary structures despite the fact that
their ‘expertise’ may derive from different bodies of
domain knowledge. Due to their capability of
exchanging information, despite their heterogeneity,
software agents appear to be the most suitable
technology able to deal with this kind of problem.
In relation to the third issue (i.e. openness), there is a
growing amount of evidence that consensus methods
may outperform the accuracy of single predictors
[48]. Although MASSP has been designed and
implemented to exploit this phenomenon on a
local basis, nothing prevents the extension of this
approach in such a way that remote predictors may
become part of the overall population of experts.
This is relatively easy to do by resorting to software
agents, as they are also particularly well-suited to
acting as wrappers, each hiding the details of the
corresponding remote predictor while interacting
with other experts involved in the prediction activity.
Stem cell analysis and simulation
In recent years, there has been a growing debate
about how stem cells behave in the human body;
whether the fate of stem cells is pre-determined
or stochastic, and whether the fate of cells relies
on their internal state, or on extra-cellular micro-
environmental factors. More recent experimental
evidence has suggested that stem cell development
may be more complicated than was originally
thought [49]. New theories challenged the prevailing
view suggesting that stem cell fate is both reversible
(cells can become less differentiated or behave more
like stem cells) and plastic (cells can migrate from one
cell lineage to another). More recently, there has
been a growing body of work that is concerned
with building predictive formal models of stem cell
behaviour that can be simulated. In this direction,
much work has been done in building agent-based
simulations of stem cells [50–53].
Work to date has used existing, well-established
techniques for specifying and modelling agent-based
systems in general [54] and progressed along two
parallel strands. The first strand has been an attempt
to develop an agent-based model of Theise’s theory
of stem cell behaviour and organization [53].
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The second strand has been to use the same agent-
based approach to analyse and re-develop existing
models to ensure that the agent framework is
sufficiently flexible to model more than one theory
and to understand how other work differs.
Two of the most common approaches to formal
models of stem cells use cellular automata [55] and
equational or probabilistic models [56]. In order to
support the claim that the agent approach is more
suitable than other modelling approaches, existing
approaches have been taken and re-cast in the agent-
based modelling and simulation framework, which
has demonstrated a number of clear advantages of
the agent approach over existing approaches [57].
Specifically, the agent model has more biological
plausibility, and is thus appropriate as a computer
modelling metaphor for interdisciplinary collabora-
tion between modellers and wet lab experimentalists.
For example: in the CA models, cells magically
appear; in the probabilistic-based models cells have
access to global system information; and in the
differential-based models we cannot begin to
investigate how individual cell–cell interaction leads
to the well-documented global system behaviour of
cell systems. This is not to say that agents are in any
way better than other approaches in general; each has
its own merits, of course. It is simply that in this
context the agent-based approach has, to date,
demonstrated a clear number of advantages.
Furthermore, arguably the most sophisticated
current equational-based model of stem cell activity,
has been re-caged in an agent framework, demon-
strating a number of clear advantages. First, it shows
how the environment may limit the behaviour
of cells. For example, division is not necessarily
guaranteed if there is insufficient space. The agent-
based simulation increases the biological intuition
and plausibility, and allows the investigation
of behaviours due to subtle changes in micro-
environmental effects for each cell. This was not
possible before. Modelling cells as agents responding
autonomously to their local environment is much
more fine-grained than using an equational/
probabilistic-function approach to model cell transi-
tions, and therefore allows for a much greater degree
of sophistication in the possibilities of understanding
how self-organization actually takes place in the
adult human body.
In this view, the agent approach is more
biologically plausible since it does not rely on getting
information about the overall system state, and
instead its behaviour is based solely on its internal
state, its perception of the local environment state,
and the actual physical state of the local environ-
ment. Biological plausibility at this abstract model-
ling level is important to attract biologists to use and
work with models and simulations in general. Stem
cells are a prime example of a self-organizing system
where individual agents react to their local physical,
chemical and biological environment.
To date, we have produced formal and mutually
consistent specifications of the leading of many of the
key predictive models of stem cell behaviour within
our agent framework. In addition, we have produced
simulations and visualizations of these models. And
having worked in this field now for around 3 years, it
is our belief that visualization of stem cell simulations
may hold the key for the integration of new models
of stem cell organization into the wet lab culture.
Moreover, using the application of our agent
framework we have introduced more biological
plausibility to the models (cells as agents is a natural
and engaging metaphor for biologists), we have
introduced cell mechanisms in place of statistical or
probabilistic methods that rely on information about
the entire cell population being instantaneously
available to all cells, we have produced visualizations
that enable a dialogue between wet lab researchers,
and we have made predictions about stem cell
behaviour that can be investigated in the wet lab. For
example, according to our models, stem cell activity
pulses around the stem cell niche. We are currently
in negotiation with stem cell laboratories to develop
an experiment to test our hypothesis relating to this
system behaviour (predictions about individual cells
cannot be tested in the human body) and thus the
corresponding model on which it is based. We are
aware of course, that our model is incredibly simple
compared with the sophistication of the human
body. Nevertheless, we are increasingly confident
that the theoretical simplifications inherent in any
model will provide crucial understandings into cell
interaction mechanisms, and that the agent metaphor
provides exactly the right metaphor for continued
interdisciplinary collaboration between biologists and
the developers of predictive models.
FUTURE CHALLENGES
In this section, we report on several areas for which
agents appear to offer a promising technology in
support of a new approach.
52 Merelli et al.
 at G
oldsm
iths College Library on January 28, 2014
http://bib.oxfordjournals.org/
D
ow
nloaded from
 
Analysis of mutant proteins: an exercise in motivation
A potential application of agents could be the
problem of collecting data on mutations and
analysing their effects on protein structure. Many
diseases are caused by DNA mutations which
lead to protein mutations: cystic fibrosis, Favism
(G6PD), Niemann Picks disease, OTC deficiency
(urea cycle—hyper-ammonaemia—brain damage),
Cancer (p53, BRCA-1, APC, MYH). Often,
biologists who study protein mutations attempt to
analyse the protein structure, since structure deter-
mines function. Could agents in some way help to
provide an answer to the problem of verifying SNPs
and confirming whether they are coding, leading to a
protein mutation [58]? If so, where is the mutation in
the protein sequence and is there a structure already
known for such proteins? How does the mutation
affect the structure? We could encode a workflow to
describe the possible answers to these questions.
The automation of the workflow implies mid-
dleware suitable for supporting the specification,
execution and coordination of very complex activ-
ities. The use of information agents, in the context
of the semantic web, could help significantly in
retrieving and integrating meaningful information
from heterogeneous and distributed data repositories.
In collecting information from diverse sources,
however, technology is often not the problem:
ontologies, web services and agent-based systems are
all well-established [59]. Rather, the problem can be
in persuading the biologist to agree to use ontologies
(The Open Biomedical Ontologies website lists all
the available ontologies in the biomedical field
http://obo.sourceforge.net/) and nomenclatures
[60]. If the technologies are too complex, or
perceived to be too complex, then why should the
biologist bother? They need to see a direct benefit in
making use of such systems. Clearly, if one
technology is obviously better than another, then
there will be no hesitation in its adoption. However,
what may be ‘better’ for the community as a whole
may not be of direct benefit to an individual
biologist. In addition, the technology may well be
so outside the scope of expertise of a bench biologist
that he or she has no concept of how and why it may
be useful. Thus, the problem is one of motivation—
persuading the biologist who may have collected
some interesting data and put it up on the web (e.g.
one of the several hundred websites listing mutations
for specific proteins [61]), to adopt standards and
ontologies [62] that can be used by agents and the
semantic web. Thus, to be successful, biologists,
bioinformaticians and computer scientists must work
closely, but most importantly, must be driven by the
needs of the biologist.
LIMS as an agent-based laboratory
An area that would certainly benefit from the agent
paradigm is that of Laboratory Information
Management Systems (LIMS). More than 160
packages and programs [63] are available for
laboratory automation necessities. Most of them
represent commercial products, provided from hard-
ware vendors, specifically designed for their labora-
tory machinery and solutions. The enormous
amount of data and metadata [64] produced from
high-throughput technologies and projects in the
plethora of ‘-omics’ fields (e.g. genome sequencing,
microarrays and transcriptomics, proteomics) and
in a number of others (e.g. immunofluorescence
imaging, flow cytometry, chemical analysis, envir-
onmental sciences) require such an information
management framework. Very little academic
research has been performed on this topic, mainly
because of its very strict connection to dedicated
equipment and to laboratory-specific data format,
requirements and procedures. Without aiming to
be exhaustive, we can cite some ad-hoc academic
solutions to specific problems: QuickLIMS [65]
developed for microarrays production, MMP-LIMS
[66] used for integrated genetic and physical map in
the maize genome project, CLIMS [67] for a
crystallography laboratory and the LIMS setup for
building the Pseudomonas aeruginosa gene collection
[68]. LabBase [69] represented a general-purpose
database management system for implementation
of laboratory information systems. Based on a
community-agreed data model and already looking
in the e-Science dimension is the MOLE project
[63] aiming to serve protein production laboratories
in the UK and Europe.
The requirements for a system that would be
flexible, scalable and capable to easily adapt to any
change, without engendering any traumatic event
for the laboratory [70] are evident. It should also be
noted that until recently automation has focused
primarily on improving hardware. Future advances
will concentrate on intelligent software to integrate
physical experimentation and result analysis with
hypothesis formulation and experiment planning
[64, 71]. We argue that the agent metaphor,
integrated with appropriate and detailed domain
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ontologies, could intuitively describe and manage
distributed environments populated by autonomous
entities that wrap robotized stations, interface human
operators, describe laboratory objects (e.g. samples,
well, plates), operations and procedures. Intelligent
agents would also be capable of successfully coping
with fast-changing (due to the ever increasing
technological turnover) and unpredictable
conditions.
Cellular processes modelling
The modelling of cellular processes is difficult due to
the complexity of the organization of biological
systems and of its cellular processes. Modelling
complex systems implies a deep understanding of
the system both in terms of its structure and its
behaviour [13]. Once we have identified some
of the components, some of their functions, their
topological relationships and the parameters of each
relation, we can start to analyse the system behaviour
trying to understand the mechanisms behind the
robustness and stability of the system. At present,
the unavailability of complete knowledge, leads to
an unavoidable degree of uncertainty in our models.
To this end, agent technology can be exploited to
develop a suitable conceptual framework for simula-
tion in order to analyse system behaviour and
eventually to infer new components and functions.
One proposed exercise is to analyse the cell in terms
of the known active components, the roles and
behaviours these play in the cell processes, their
interactions with the living environment. But, in
approaching the agent-based cell simulation, at what
abstraction level should we model the cell system—
the fine grained level? What would be the main
features of an agent-based conceptual framework
for simulation of biological systems? What would
be a good bioagent conceptual language?
Based on the consideration that biological systems
are complex, consisting of a set of components
interacting with each other and with an external
(dynamic) environment, a conceptual framework
for engineering an agent society that simulates the
behaviour of a biological system has been proposed
[72]. In contrast to the classical mathematical
descriptions mainly based on ordinary differential
equations, the specification of complex systems is
based on behavioural modelling. For example, an
agent-based model of the carbohydrate oxidation in
the cell, describing each engineering step by Unified
Modelling Language (UML) graphical notation has
already been suggested [73]. Other recent examples
of application of agent technology in systems biology
concern the tissue homeostasis in human epidermis
[74], bacterial chemotaxis [75], molecular self-
organization [76] and T-cell recognition [77].
Other approaches, not agent-based, are relevant in
the cell modelling and simulation context: Cell-
DEVS [78], based on discrete-events systems speci-
fication, E-CELL [79], for modelling biochemical
and genetic processes, Virtual Cell [80], a general
framework for the spatial modelling and simulation
of cellular physiology and Physione [81], for mod-
elling human body from a fine to coarse grain level.
Formal and semiformal methods in bioinformatics
In addition to the expected contribution of agents
in bioinformatics as a technological framework,
we see another challenge to deal with, i.e. the
possibility of designing incredibly complex systems,
through models suitable for representing and analys-
ing biological systems from different viewpoints:
static-structural, dynamic and functional [73, 82].
In fact, the use of models to represent a biological
system at different abstraction levels helps us to
understand the biological system itself. The specifi-
cation model, e.g. agent-oriented, can help by
identifying the system structure, critical component
roles and responsibilities, functions and interactions
(which are generally poorly identified). Of course,
to create models we need languages and suitable
notations.
In the literature, a wide range of formal and semi-
formal languages and notations can be found. These
depend on the level considered, on the properties in
which the designer is interested, and on the tools
available to perform the analysis and verify proper-
ties. Proving properties in biological models can
mean verifying properties related to the system/
process behaviour (e.g. safety properties; liveness
properties; simulations of system dynamics; checking
for causal relationships . . .). Any property can be
formally proved by using well-known methods such
as equivalence checking, model checking, simulation
and model synthesis.
In a very simple scenario, a semi-formal notation,
based on PetriNets [82] and UML Activity Diagrams
[83], is used to graphically describe the workflow
activities for a biological process. In particular,
Figure 1 shows four different models to represent
the malaria parasite invading human host erythrocytes
system at different levels of abstraction with bold
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arrows indicating the steps (modelling, analysing,
simulation and validation) to derive one model from
another.
Starting form the biological knowledge of a
system, a graphical (semi-formal) description can be
derived. Then on the one hand, this model is
translated to a formal specification (by process
algebra) to verify the model’s properties, and on
the other hand, the graphical description can be
compiled into a low-level specification (in an agent-
oriented language) to generate the agent-based
simulation of the biological system. The last step,
the software validation [84] of the multi-agent
system [85], can give rise to an enrichment of the
formal model by including properties to make the
model more faithful to the biological system [86].
The natural question, therefore, is how we can know
what kind of system properties biologists want to
verify. Are they interested in having clear evidence
of how the simulation system behaves, being able to
modify the system’s properties at run-time? And
should it be possible to incrementally build, maintain
and refine the system? What kind of conceptual
simulation framework would be useful to fulfil
biologists’ expectations? Would an agent approach
be sufficient to create a framework with these
features [72]? Would mobility be a meaningful
feature to simulate biological systems through agent
technology? (Note that in Figure 1 some system
components are mobile.)
CONCLUSION
It is clear that the combination of agents and
bioinformatics presents a 2-fold opportunity. On
the one hand, the domain of bioinformatics, with its
extensive and growing resources of databases and
analysis tools, provides an appropriate domain for the
application of agent technologies. It offers the
possibility for deploying and testing agent systems
in a real-world setting with the possibility of making
substantial contributions to human society. On the
other hand, there is a distinct and identified need for
good solutions to improve the performance of
existing bioinformatics systems, and agents may be
able to contribute to that improvement. In this sense,
there is a very strong synergy between the two
domains.
This picture is both enhanced and complicated
by the introduction of relevant infrastructural
technologies that facilitate both bioinformatics and
agent-based computing. For example, the Grid
has become increasingly important to both the
communities, and suggests a convergence to a
service-oriented vision of bioinformatics under-
pinned by Grid-based virtual organizations.
However, there are still significant challenges.
Researchers from both communities generally
require education in the other, and work must be
undertaken to ensure that any solutions across both
areas satisfy both needs. In many cases, the language
of discourse is so distinct that discussion of key issues
becomes problematic. Additionally, the introduction
of new technologies like the Grid requires further
efforts, both in terms of understanding and adoption,
and in terms of its immaturity in fully deployed
systems. Maturity at the interface is thus the key
challenge. While many agent techniques may be
used to address the concerns of bioinformaticians, the
lack of a complete understanding across domains
suggests that it may still be too early to develop more
sophisticated systems than the current generation of
essential management and mediation systems.
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